.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Patients battling ovarian cancer often face a complex array of concurrent symptoms known as psychoneurological symptom clusters. These clusters typically include fatigue, insomnia, depression, and anxiety, which frequently manifest together rather than in isolation. Consequently, these symptoms can lead to treatment interruptions, reduced survival rates, and a significantly diminished quality of life. While conventional treatments focus on tumor reduction, effective management strategies for these interconnected symptoms remain limited. Therefore, researchers are investigating integrative protocols like the TiaoShenZhiAi (TSZA) regimen to provide a more holistic approach to symptom relief.
The TSZA regimen is an innovative intervention that combines traditional herbal medicine with modern psychological support. Specifically, the regimen utilizes Compound Ciwujia Granules, which contain Acanthopanax senticosus and Schisandra chinensis. These herbs are traditionally recognized for their adaptogenic and neuroprotective properties. Moreover, the protocol pairs this pharmacological approach with structured psychological intervention to address the emotional components of the symptom cluster. A multicenter, double-blind, randomized controlled trial is currently underway to evaluate the efficacy of this combined strategy against a low-dose active control.
The primary goal of this clinical trial is to determine the remission rate of psychoneurological symptom clusters at the three-month mark. In addition to primary outcomes, investigators are tracking secondary measures such as sleep quality, fatigue scales, and one-year survival rates. Furthermore, the study incorporates sophisticated exploratory indicators, including functional magnetic resonance imaging (fMRI) and biomarkers of the hypothalamic-pituitary-adrenal (HPA) axis. These biological markers will help clarify the underlying mechanisms by which the TSZA regimen influences the central nervous system and immune function. Eventually, this data may provide a blueprint for integrating traditional medicine into standard oncological care.
Effective management of symptom clusters requires a transition from treating single symptoms to addressing the synergy between psychological and neurological distress. Because traditional Chinese medicine often emphasizes systemic balance, it offers a unique framework for managing multi-symptom burdens. This study represents a rigorous attempt to validate such approaches through high-level clinical evidence. If successful, the TSZA regimen could become a standard supportive care option, helping patients maintain treatment adherence and improve their overall prognosis.
They are groups of three or more concurrent symptoms, such as pain, fatigue, and depression, that share a common underlying mechanism and impact patient outcomes more severely than individual symptoms.
It combines herbal granules (Acanthopanax and Schisandra) with psychological counseling to simultaneously target the biological and emotional drivers of cancer-related distress.
Many patients suffer from debilitating side effects that lead to treatment discontinuation. This trial seeks a safe, integrative way to stabilize these symptoms and improve long-term survival.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a qualified healthcare provider regarding any medical condition or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Liu Z et al. Evaluation of the TiaoShenZhiAi Regimen for Patients With Ovarian Cancer Experiencing a Psychoneurological Symptom Cluster: Protocol for a Multicenter, Double-Blind, Randomized Controlled Trial. JMIR Res Protoc. 2026 Jun 12. doi: 10.2196/88625. PMID: 42284089.
Huang J et al. Symptom Clusters in Ovarian Cancer Patients With Chemotherapy After Surgery: A Longitudinal Survey. Cancer Nurs. 2016;39(2):106-16.
Cazeau N. Understanding the Psychoneurological Symptom Cluster in Adults With Hematologic Malignancies. Oncology Nursing News. 2026.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Psychoneurological symptom clusters (PNSCs) significantly impair the quality of life for ovarian cancer patients. This study protocol evaluates the TiaoShenZhiAi (TSZA) regimen, an integrative approach combining herbal therapy and psychological intervention to improve patient outcomes and survival.
2 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
